Psyence announces a SPAC merger and filing with the SEC for eventual NASDAQ trading. The post Psyence Announces SEC Registration For NASDAQ (by SPAC Merger)...
Awakn Life Sciences has sold its last clinic and shifted its focus entirely to its clinical trials and biotech research. The post Awakn Life Sciences...
Cybin has announced a public offering for gross proceeds of US$8,250,000. The post Raising Capital: Cybin Announces Public Offering appeared first on ...
See Microdose's exclusive Q&A with Terran’s founder and CEO to learn more about the company and their recent discoveries. The post EXCLUSIVE: Interview...
Psychedelics made their official debut in the Western world over half a century ago. However, there are still a lot of unknowns. The large gap in...
Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed The post News...
Cybin announces Phase 2 cohort 5 dosing completion of CYB003 in Major Depressive Disorder The post Cybin Announces Phase 2 Dosing Completion of CYB003...
Kernel, a leader in non-invasive neuroimaging, announces the publication of their study “Measuring acute effects of subanesthetic ketamine on cerebrovascular...
This story was reprinted with permission from Crain New York and written by Amanda D’Ambrosio. Last month, federal regulators released research guidance...
PharmaTher Announces Positive Research Results for PharmaPatch™ with N,N-dimethyltryptamine (DMT) and Strategic Investment into Sairiyo Therapeutics The...